Hi @Bouncing
The next trial that will start later this year, is an adaptive 2/3 trial for which the FDA has already advised they will consider accelerated approval at the 24 week mid trial results. This I understand is reliant on gaining Orphan Drug Designation status. The shelf life is also considerable so making a bulk batch will not go to waste.
Cheers
- Forums
- ASX - By Stock
- Ann: PharmAust makes Head of Manufacturing appointment
Hi @Bouncing The next trial that will start later this year, is...
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
20.0¢ |
Change
-0.015(6.98%) |
Mkt cap ! $91.22M |
Open | High | Low | Value | Volume |
19.5¢ | 20.5¢ | 19.5¢ | $323.7K | 1.637M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 576351 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 291638 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 576351 | 0.200 |
8 | 292109 | 0.195 |
16 | 917212 | 0.190 |
18 | 482166 | 0.185 |
13 | 109248 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 291638 | 4 |
0.210 | 187184 | 6 |
0.215 | 385107 | 6 |
0.220 | 506039 | 7 |
0.225 | 420666 | 1 |
Last trade - 11.27am 25/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
Previous Video
Next Video
SPONSORED BY The Market Online